Early Access — free while we kick the tires
EdgarHawk

Carrillo Antonio

President & CEO

Director Officer
2 filings analyzed · 1 company · Latest 2025-03-10

Companies

Company Buys Sells Direction
Arcosa, Inc. ACA 5 0 Net buying

Activity

March 2025
2025-03-10 Arcosa, Inc. ACA
high
Buy
6,345 shares
$498,438
Significance 8/10

Arcosa CEO Carrillo purchases 6,345 shares for $498,438.30 amid -22.8% 30-day decline; 5 of 5 prior ACA trades well-timed at 90-day mark

President & CEO Carrillo Antonio executed 2 open-market purchases totaling 6,345 shares for $498,438.30 on 2025-03-10 at a blended average price of $78.56, bringing his holdings to 433,283 shares. This acquisition occurs as ACA trades at $78.55, representing -22.8% decline over 30 days and -26.6% over 90 days from recent levels, though the stock remains -29.6% below its 52-week high of $111.57. Notably, Carrillo's prior 5 transactions at ACA exhibited a 100% well-timed rate at the 90-day mark, with 3 prior purchases on 2024-08-08 each delivering between +25.4% and +28.2% 90-day returns following their execution. His cross-ticker buy track record shows a 100% 90-day win rate across 3 prior buys with a +26.6% average 90-day return, establishing a pattern of favorable long-term timing on accumulations. Investors should evaluate whether current price weakness and prior demonstrated timing pattern at this specific ticker are material inputs to conviction in future performance.

August 2024
2024-08-09 Arcosa, Inc. ACA
high
Buy
12,125 shares
$994,909
Significance 7/10

CEO Carrillo Antonio bought 12,125 shares for $994,908.79 across 3 transactions at ACA on 2024-08-08

Carrillo Antonio, President & CEO of Arcosa Inc., purchased 12,125 shares across 3 separate open-market transactions totaling $994,908.79, raising his holdings from 394,150 to 406,275 shares (+3.1%). The purchases occurred at prices ($80.46, $81.80, $82.27) near current market levels ($81.33), during a period when the stock has declined 1.4% over 30 days and 7.9% over 90 days from recent highs. His prior trading history at ACA spans 5 sales in August 2023, all of which proved well-timed at the 90-day mark (stock fell after each sale), suggesting a pattern of disciplined price-aware trading; this buy occurs nearly a year after that cluster of sales. The company's fundamentals show $664.7M quarterly revenue, 2.9% annual growth, and a P/E of 26.93, indicating a moderately-valued established business rather than a distressed or undervalued turnaround situation.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access